Table III.
Screening strategies | Total, n | dMMR tumor, n (%) | bf-GTC, n (%) | LS, n (%) |
---|---|---|---|---|
Universal screening | 463 | 34 (7.3) | 10 (2.2) | 2 (0.4) |
≤49 years | 33 | 3 (9.1) | 3 (9.1) | 2 (6.1) |
≤69 years | 232 | 15 (6.5) | 8 (3.4) | 2 (0.9) |
≥70 years | 231 | 19 (8.2) | 2 (0.9) | 0 (0.0) |
dMMR, deficient mismatch repair; bf-GTC, bona fide genetic testing candidate; LS, Lynch syndrome; GTC, genetic testing candidate.